AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGRX

<< 이전 1 2 3 4 5 6 7 8 9 10 11 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/09/29	05:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/09/05	21:05	GlobeNewswire Inc.	Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:AGRX	Agile Therapeutics Inc
2023/08/26	05:02	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/08/22	21:30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:AGRX	Agile Therapeutics Inc
2023/08/10	05:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AGRX	Agile Therapeutics Inc
2023/08/09	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/08/09	21:05	GlobeNewswire Inc.	Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/26	21:30	GlobeNewswire Inc.	Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/01	05:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/01	05:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/01	05:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/01	05:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/01	05:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/07/01	05:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/28	05:47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/26	21:01	GlobeNewswire Inc.	Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/24	01:05	GlobeNewswire Inc.	Agile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/16	05:05	GlobeNewswire Inc.	Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s Health	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/15	05:36	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/14	05:05	GlobeNewswire Inc.	Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/10	06:20	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/10	06:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/10	06:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/06/10	06:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/05/26	06:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/05/26	05:05	GlobeNewswire Inc.	Agile Therapeutics Announces Closing of $7.5 Million Public Offering	NASDAQ:AGRX	Agile Therapeutics Inc
2023/05/26	01:28	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/05/25	05:22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:AGRX	Agile Therapeutics Inc
2023/05/23	09:00	GlobeNewswire Inc.	Agile Therapeutics Announces Pricing of $7.5 Million Public Offering	NASDAQ:AGRX	Agile Therapeutics Inc
2023/05/20	01:21	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:AGRX	Agile Therapeutics Inc